QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=DE304EC9CDF11B7124964268841F1366;jsessionid=C57F5F3FC8F419FF7AD96B2ECA778D7B;jsessionid=3ACD09F817AA1AAD96152125B136533F;jsessionid=B77BD6538144277A230E9B8C1BE5BFDE;jsessionid=1004084CFA6083D29A324360A6521660;jsessionid=F63C4213577D555443D14B2387109596;jsessionid=A4C284EE83B57AE459145200FF499D56;jsessionid=AD9C1A94A31AEFAC856CA48E05A55FC5 (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. ATXN2 is a target of N-terminal proteolysis.
3. A Case of Coexistent Spinocerebellar Ataxia Type 2 and Primary Progressive Multiple Sclerosis-Coinci…
4. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
5. TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=DE304EC9CDF11B7124964268841F1366;jsessionid=C57F5F3FC8F419FF7AD96B2ECA778D7B;jsessionid=3ACD09F817AA1AAD96152125B136533F;jsessionid=B77BD6538144277A230E9B8C1BE5BFDE;jsessionid=1004084CFA6083D29A324360A6521660;jsessionid=F63C4213577D555443D14B2387109596;jsessionid=A4C284EE83B57AE459145200FF499D56;jsessionid=AD9C1A94A31AEFAC856CA48E05A55FC5